DEA Placement of MAB-CHMINACA in Schedule I

The U.S. Drug Enforcement Administration has issued the following final rule:

Schedules of Controlled Substances: Placement of MAB-CHMINACA in Schedule I

Drug Enforcement Administration, Department of Justice; January 29, 2019

Official notice in the Federal Register here

Supporting document:

Schedules of Controlled Substances: Placement of N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA) into Schedule 1

The Drug Enforcement Administration places N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1 H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act.